• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Identifying novel molecular markers of human hepatocellular carcinoma

Research Project

Project/Area Number 17591397
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionOsaka University

Principal Investigator

TAKEDA Yutaka  Osaka University, Graduate School of Medicine, Assistant, 医学系研究科, 助手 (90397696)

Co-Investigator(Kenkyū-buntansha) DONO Keizo  Osaka University, Graduate School of Medicine, lecturer, 医学系研究科, 講師 (60283769)
NAGANO Hiroaki  Osaka University, Graduate School of Medicine, lecturer, 医学系研究科, 講師 (10294050)
MIYAMOTO Atsushi  Osaka University, Graduate School of Medicine, Assistant, 医学系研究科, 助手 (00362731)
MARUBASHI Shigeru  Osaka University, Graduate School of Medicine, Assistant, 医学系研究科, 助手 (20362725)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2006: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2005: ¥1,900,000 (Direct Cost: ¥1,900,000)
Keywordsnovel molecular markers of human hepatocellular carcinoma / DNA microarray analysis
Research Abstract

Samples from 100 HCC tissues and 7 normal livers without virus infection were obtained with informed consent from patients who underwent hepatic resection at Osaka University Hospital from 1997 to 2003. Gene expression profiling of primary HCC tumors from 100 patients was examined by human 30K DNA microarray(AceGene Human 30K; DNA Chip Research Inc and Hitachi Software Engineering Co., Yokohama Japan). The gene expression data were uploaded into the network analysis tool (Ingenuity systems, Mountain View, CA; http://www.ingenuity.com). We identified several activated "hotspot" regions containing a concentration of upregulated genes, and further focused on several of these genes. Several "hotspot" regions revealed integrin and Akt/NF-□B signaling as activated pathways in HCC. We identified key members linked to these signaling pathways including osteopontin (SPP1), glypican-3 (GPC3), vimentin (VIM), and more two genes. We compared gene expression levels generated from quantitative RT-PCR with those from microarray analysis by Pearson's correlation coefficients for each candidate gene. Each of the five genes analyzed showed significant correlation and confirmed the results obtained by DNA microarray. Immunohistochemical staining revealed colocalization of these genes in 15 (75%) of 20 human HCC samples. We discovered several molecules commonly upregulated in HCC as potential key players in this disease.

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (17 results)

All 2006

All Journal Article (17 results)

  • [Journal Article] TGF-betal-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.2006

    • Author(s)
      Damdinsuren B., et al.
    • Journal Title

      Oncol Rep 15(2)

      Pages: 401-408

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma : a comparative study with hepatocellular carcinoma and cholangiocellular carcinom.2006

    • Author(s)
      Tang D., et al.
    • Journal Title

      J Gastronitest Surg 2006 10(7)

      Pages: 987-998

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Expression pattern of angiogenic factors and prognosis afte hepatic resection in hepatocellular carcinoma : importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.2006

    • Author(s)
      Wada H., et al.
    • Journal Title

      Liver International 26

      Pages: 414-423

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] A case of hepatocellular carcinoma with multiple lung, spleen and remnant liver metastasis successfully treated by combination chmotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-α.2006

    • Author(s)
      Nakamura M., et al.
    • Journal Title

      J Gastroenterol 10(1007)

      Pages: 1120-1125

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.2006

    • Author(s)
      Nakamura M., et al.
    • Journal Title

      Hepatology Research 35

      Pages: 289-295

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] TGF-beta 1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.2006

    • Author(s)
      Damdinsuren B et al.
    • Journal Title

      Oncol Rep. 15(2)

      Pages: 401-8

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma : a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.2006

    • Author(s)
      Tang D et al.
    • Journal Title

      J Gastrointest Surg 10(7)

      Pages: 987-98

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma : importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.2006

    • Author(s)
      Wada H et al.
    • Journal Title

      Liver International. 26(4)

      Pages: 414-23

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.2006

    • Author(s)
      Nakamura M et al.
    • Journal Title

      J Gastroenterol. 10(1007)

      Pages: 1120-1125

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.2006

    • Author(s)
      Nakamura M et al.
    • Journal Title

      J Gastroenterol. Epub

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.2006

    • Author(s)
      Nakamura M et al.
    • Journal Title

      Hepatol Reserch. 35(4)

      Pages: 289-295

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.2006

    • Author(s)
      Nakamura M et al.
    • Journal Title

      Hepatol Reserch. Epub

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] TGF-betal-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.2006

    • Author(s)
      Damdinsuren B., Nagano H., Kondo M., Natsag J., Hanada H., Nakamura M., Wada H., Kato H., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Monden M.
    • Journal Title

      Oncol Rep 15(2)

      Pages: 401-408

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma : a comparative study with hepatocellular carcinoma and cholangiocellular carcinom.2006

    • Author(s)
      Tang D., Nagano H., Nakamura M., Wada H., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Monden M.
    • Journal Title

      J Gastronitest Surg 2006 10(7)

      Pages: 987-998

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma : importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.2006

    • Author(s)
      Wada H., Nagano H., Yamamoto H., Yang Y., Kondo M., Ota H., Nakamura M., Yoshioka S., Kato H., Damdinsuren B., Tang D., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Nakamori S., Sakon M., Dono K., Wakasa K., Monden M.
    • Journal Title

      Liver International 26

      Pages: 414-423

    • Related Report
      2006 Annual Research Report
  • [Journal Article] A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chmotherapy with the novel oral DPD- inhibiting chemotherapeutic drug S-1 and interferon-α.2006

    • Author(s)
      Nakamura M., Nagano H., Wada H., Noda T., Ota H., Damdinsuren B., Marubashi S., Miyamoto A., Takeda Y., Umeshita k., Dono K., Monden M.
    • Journal Title

      J Gastroenterol 10(1007)

      Pages: 1120-1125

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.2006

    • Author(s)
      Nakamura M, Nagano H, Noda T, Wada H, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Doki Y, Umeshita K, Dono K, Sakon M, Monden M.
    • Journal Title

      Hepatology Research 35

      Pages: 289-295

    • Related Report
      2006 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi